
Cigna Corporation
CINYSEHealthcareMedical - Healthcare Plans
Previous close
$277.51
+$3.10 · +1.13%
CI company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
96
Deep Value
Momentum
44
Neutral
Sentiment
61
Bullish
Risk resilience
82
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteCigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Brian C. Evanko
- Listed since
- Mar 31, 1982
- Employees
- 66,685
Market position
Day range
Current $277.51
52-week range
Current $277.51
- Open
- $274.79
- Previous close
- $274.41
- Volume
- 1.07M
- 0.63× average
- Average volume
- 1.7M
- Average daily volume
- Market cap
- 73.33B USD
- Beta
- 0.32
- Market reference 1
- 50-day average
- $284.68
- -2.52% below average
- 200-day average
- $278.81
- -0.46% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 96.98B USD
- P/E (TTM)
- 11.44×
- P/B (TTM)
- 1.72×
- P/S (TTM)
- 0.26×
- EV / EBITDA
- 8.36×
- Earnings yield
- 8.14%
- Free cash flow yield
- 11.46%
- Dividend yield
- 2.21%
Profitability & efficiency
- Gross margin
- 11.66%
- Operating margin
- 3.46%
- Net margin
- 2.27%
- Return on equity
- 14.28%
- Return on assets
- 3.77%
- Return on invested capital
- 7.35%
Financial health
- Debt / equity
- 0.75×
- Current ratio
- 0.85×
- Altman Z-score
- 2.77
- Piotroski F-score
- 8 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 274.95B USD | 247.12B USD | 195.27B USD | 180.52B USD | 174.07B USD |
| Cost of goods sold | 248.97B USD | 221.16B USD | 170.09B USD | 157.02B USD | 151.12B USD |
| Gross profit | 25.99B USD | 25.96B USD | 25.18B USD | 23.5B USD | 22.95B USD |
| Selling, general, and administrative | 14B USD | 14.57B USD | 14.32B USD | 13.05B USD | 12.79B USD |
| Operating expenses | 16.86B USD | 16.55B USD | 16.64B USD | 15.05B USD | 15.01B USD |
| Interest expense | 1.38B USD | 1.44B USD | 1.45B USD | 1.23B USD | 1.21B USD |
| Depreciation and amortization | 2.63B USD | 1.75B USD | 1.81B USD | 1.86B USD | 1.8B USD |
| Operating income | 9.13B USD | 9.42B USD | 8.54B USD | 8.45B USD | 7.94B USD |
| Net income | 5.96B USD | 3.43B USD | 5.16B USD | 6.7B USD | 5.37B USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 91%
- 10 beats, 1 miss, 0 met estimates
- Average EPS surprise
- +1.62%
- 11 comparable reports
- Latest EPS result
- 7.78
- Estimate 7.6 · Beat by 2.37%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$338.33
21.92% upsideRating distribution
39 ratingsRecent analyst actions
CI news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$6.04
2025 complete year+51.0% since 2021
2026 partial: $3.12
$4.00
2,021
$4.48
2,022
$4.92
2,023
$5.60
2,024
$6.04
2,025
$3.12
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 8, 2026 | $1.56Quarterly | Sep 8, 2026 | Sep 23, 2026 |
Dividend | Jun 4, 2026 | $1.56Quarterly | Jun 4, 2026 | Jun 18, 2026 |
Dividend | Mar 5, 2026 | $1.56Quarterly | Mar 5, 2026 | Mar 19, 2026 |
Dividend | Dec 4, 2025 | $1.51Quarterly | Dec 4, 2025 | Dec 18, 2025 |
Dividend | Sep 4, 2025 | $1.51Quarterly | Sep 4, 2025 | Sep 18, 2025 |
Dividend | Jun 3, 2025 | $1.51Quarterly | Jun 3, 2025 | Jun 18, 2025 |
Ex-dividend Sep 8, 2026
$1.56
Quarterly
Record Sep 8, 2026 · Payment Sep 23, 2026
Ex-dividend Jun 4, 2026
$1.56
Quarterly
Record Jun 4, 2026 · Payment Jun 18, 2026
Ex-dividend Mar 5, 2026
$1.56
Quarterly
Record Mar 5, 2026 · Payment Mar 19, 2026
Ex-dividend Dec 4, 2025
$1.51
Quarterly
Record Dec 4, 2025 · Payment Dec 18, 2025
Ex-dividend Sep 4, 2025
$1.51
Quarterly
Record Sep 4, 2025 · Payment Sep 18, 2025
Ex-dividend Jun 3, 2025
$1.51
Quarterly
Record Jun 3, 2025 · Payment Jun 18, 2025
CI peers
ETFs holding CI
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI2.35B0.10%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO1.94B0.11%1.7T USD0.03%$703.71+0.39%
iShares Core S&P 500 ETFIVV978.11M0.11%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY902.71M0.11%817.87B USD0.09%$765.72+0.41%
Vanguard Morningstar Value ETFVTV703.05M0.27%256.5B USD0.03%$226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV522.17M1.17%44.76B USD0.08%$174.62+1.29%
Vanguard High Dividend Yield ETFVYM293.35M0.30%99.2B USD0.04%$164.97+0.59%
VictoryShares Free Cash Flow ETFVFLO237.64M2.21%10.72B USD0.44%$55.45+0.69%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 2.35B
- Weight
- 0.10%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 1.94B
- Weight
- 0.11%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
iShares Core S&P 500 ETFIVV- Market value
- 978.11M
- Weight
- 0.11%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 902.71M
- Weight
- 0.11%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Vanguard Morningstar Value ETFVTV- Market value
- 703.05M
- Weight
- 0.27%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 522.17M
- Weight
- 1.17%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Vanguard High Dividend Yield ETFVYM- Market value
- 293.35M
- Weight
- 0.30%
- AUM
- 99.2B USD
- Expense ratio
- 0.04%
- Price / 1D
- $164.97+0.59%
VictoryShares Free Cash Flow ETFVFLO- Market value
- 237.64M
- Weight
- 2.21%
- AUM
- 10.72B USD
- Expense ratio
- 0.44%
- Price / 1D
- $55.45+0.69%
Continue in GoAI
Research CIresearch.disclaimer











